Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Current Deferred Revenue (2017 - 2018)

Cue Biopharma's Current Deferred Revenue history spans 2 years, with the latest figure at $381465.0 for Q4 2018.

  • For Q4 2018, Current Deferred Revenue rose 949.02% year-over-year to $381465.0; the TTM value through Dec 2018 reached $381465.0, up 949.02%, while the annual FY2018 figure was $381465.0, 949.02% up from the prior year.
  • Current Deferred Revenue for Q4 2018 was $381465.0 at Cue Biopharma, up from $225000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $381465.0 in Q4 2018 and bottomed at $36364.0 in Q4 2017.